Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66801 - 66825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ritonavir	Approved Investigational	NR1H4	9971	upregulated	Ritonavir results in increased expression of NR1H4 mRNA	12q23.1	A24086
Ritonavir	Approved Investigational	PPARG	5468	upregulated	Ritonavir results in increased expression of PPARG mRNA	3p25.2	A24089
Ritonavir	Approved Investigational	RB1	5925	upregulated	Ritonavir results in increased expression of RB1 mRNA	13q14.2	A24084
Ritonavir	Approved Investigational	RBL1	5933	upregulated	Ritonavir results in increased expression of RBL1 mRNA	20q11.23	A24084
Ritonavir	Approved Investigational	RBL2	5934	downregulated	Ritonavir results in decreased expression of RBL2 mRNA	16q12.2	A24084
Ritonavir	Approved Investigational	SCARB1	949	upregulated	Ritonavir results in increased expression of SCARB1 mRNA	12q24.31	A24089
Rofecoxib	Approved Withdrawn	ANGPT1	284	downregulated	rofecoxib results in decreased expression of ANGPT1 mRNA	8q23.1	A23026
Rofecoxib	Approved Withdrawn	ANGPTL1	9068	downregulated	rofecoxib results in decreased expression of ANGPTL1 mRNA	1q25.2	A23026
Rofecoxib	Approved Withdrawn	ANXA3	306	upregulated	rofecoxib results in increased expression of ANXA3 mRNA	4q21.21	A23026
Rofecoxib	Approved Withdrawn	ANXA9	8416	downregulated	rofecoxib results in decreased expression of ANXA9 mRNA	1q21.3	A23026
Rofecoxib	Approved Withdrawn	AOX1	316	downregulated	rofecoxib results in decreased expression of AOX1 mRNA	2q33.1	A23026
Rofecoxib	Approved Withdrawn	ARHGAP29	9411	downregulated	rofecoxib results in decreased expression of ARHGAP29 mRNA	1p22.1	A23026
Rofecoxib	Approved Withdrawn	C3	718	upregulated	rofecoxib results in increased expression of C3 mRNA	19p13.3	A23026
Rofecoxib	Approved Withdrawn	CACNA2D3	55799	downregulated	rofecoxib results in decreased expression of CACNA2D3 mRNA	3p21.1-p14.3	A23026
Rofecoxib	Approved Withdrawn	CCL2	6347	upregulated	rofecoxib results in increased expression of CCL2 mRNA	17q12	A23026
Rofecoxib	Approved Withdrawn	CDH3	1001	upregulated	rofecoxib results in increased expression of CDH3 mRNA	16q22.1	A23026
Rofecoxib	Approved Withdrawn	CLU	1191	upregulated	rofecoxib results in increased expression of CLU mRNA	8p21.1	A23026
Rofecoxib	Approved Withdrawn	COL14A1	7373	downregulated	rofecoxib results in decreased expression of COL14A1 mRNA	8q24.12	A23026
Rofecoxib	Approved Withdrawn	COLEC12	81035	downregulated	rofecoxib results in decreased expression of COLEC12 mRNA	18p11.32	A23026
Rofecoxib	Approved Withdrawn	CRISP3	10321	upregulated	rofecoxib results in increased expression of CRISP3 mRNA	6p12.3	A23026
Rofecoxib	Approved Withdrawn	CXCL8	3576	upregulated	rofecoxib results in increased expression of CXCL8 mRNA	4q13.3	A23030
Rofecoxib	Approved Withdrawn	EPHA3	2042	downregulated	rofecoxib results in decreased expression of EPHA3 mRNA	3p11.1	A23026
Rofecoxib	Approved Withdrawn	EPHB6	2051	downregulated	rofecoxib results in decreased expression of EPHB6 mRNA	7q34	A23026
Rofecoxib	Approved Withdrawn	ETV5	2119	downregulated	rofecoxib results in decreased expression of ETV5 mRNA	3q27.2	A23026
Rofecoxib	Approved Withdrawn	FABP4	2167	downregulated	rofecoxib results in decreased expression of FABP4 mRNA	8q21.13	A23026

Displaying entries 66801 - 66825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability